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Background: Marathon (42 km foot race) participation has risen steadily among middle-aged people seeking the reported health benefits of 
regular physical exercise. To date, data defining the cardio-metabolic responses to marathon preparation are sparse.
methods: Recreational male runners [n = 45; age = 48 ± 7 years; 24/45 (53%) with at least one cardiovascular (CV) risk factor] participated in a 
structured training program in preparation for the 2013 Boston Marathon. Clinical assessment, echocardiography, cardiopulmonary exercise testing, 
and laboratory evaluation were performed before and after training to quantify changes CV risk parameters.
results: Completion of an 18-week marathon training program (24.2 ± 11.9 miles/week) lead to significant changes in key determinants of 
cardiovascular risk (Fig.) including peak oxygen consumption (44.6 ± 5.2 vs 46.3 ± 5.4 ml/kg/min, p<0.001), left ventricular early (E’) diastolic 
function (12.4 ± 2.5 vs. 13.2 ± 2.0, cm/s, p=0.007), serum low-density lipoprotein (120 ± 29 vs 114 ± 26 mg/dL, p=0.01), and serum triglycerides 
(100 ± 52 vs 85 ± 36 mg/dL, p=0.02).
conclusions: Among middle-aged recreational male runners, marathon training is associated with favourable changes in key determinants of CV 
risk and/or all-cause mortality, suggesting that marathon training may represent an effective strategy for reducing CV disease risk.
